Formulary decision guides

If you want to update your knowledge on specific drugs, or need to collate information to support your formulary decisions, read our Guidelines in Practice formulary decision guides. Items may contain pharmaceutical promotional information.

Otigo FDG V7_Final

Otigo® (phenazone/lidocaine hydrochloride) 40 mg/10 mg/g ear drops, solution

Commissioned by LogixX Pharma Limited

Information intended for UK healthcare professionals only. This formulary decision guide was developed from content provided by LogixX Pharma Limited in a format developed by Guidelines in Practice. Renascience Pharma Limited carried out full medical approval to ensure compliance with regulations.
View Otigo® (phenazone/lidocaine hydrochloride) prescribing information and adverse event reporting information here
OTI-UK-028-SP
Date of preparation: June 2022

20210927 Sixmo FDG new image

Sixmo®▼ (buprenorphine) 74.2 mg implant

Commissioned by Accord UK Ltd

Information intended for UK healthcare professionals only. This formulary decision guide was developed from content provided by Accord Healthcare Limited in a format developed by Guidelines in Practice.
View prescribing information and adverse event reporting information.
UK-03417
Date of preparation: October 2021

Ipinnia XL (ropinirole hydrochloride) FDG

Ipinnia® XL (ropinirole hydrochloride) prolonged-release tablets

Commissioned by Ethypharm UK Ltd

This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13  Date of preparation: September 2021

Xaggitin XL (methylphenidate hydrochloride) FDG

Xaggitin XL (methylphenidate hydrochloride) prolonged-release tablets

Commissioned by Ethypharm UK Ltd

This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-XAG-20  Date of preparation: July 2021